← Leaderboards
Maria Maccecchini
Annovis Bio, Inc.
$2,142,786
Attributed
$2,142,786
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $975.4K · FY2010–20$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,142,786 · 2
By mechanism
U01$1,929,278 · 1
R43$213,508 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposTau ProteinsAmyloid Beta-Protein PrecursorPreventS DiseaseTartratesClinical ResearchInhibitor/AntagonistNeurotransmittersPre-ClinicalDoseRecoverySmall MoleculeAmyloid Beta-ProteinMouse ModelBrainCanis FamiliarisAnimalsNeuronsNeurotoxicOralPharmaceutical PreparationsProteinsToxic Effect
Grant awards (3)
Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs$975,429
U01 · FY2020 · AG · contact PI
Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs$953,849
U01 · FY2019 · AG · contact PI
Small molecule inhibitor of amyloid precursor protein synthesis$213,508
R43 · FY2010 · AG · contact PI